These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 32034433)

  • 21. Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts.
    Ajmal S; Mahmood M; Abu Saleh O; Larson J; Sohail MR
    Infection; 2018 Aug; 46(4):555-558. PubMed ID: 29627936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of bronchoalveolar lavage samples in immunosuppressed patients with suspected pneumonia: analysis of a protocol.
    Vélez L; Correa LT; Maya MA; Mejía P; Ortega J; Bedoya V; Ortega H
    Respir Med; 2007 Oct; 101(10):2160-7. PubMed ID: 17629473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Invasive pulmonary aspergillosis in 4 patients with acute decompensation of chronic respiratory insufficiency].
    Pouchelon E; Murris-Espin M; Didier A; Rouquet RM; Carré P; Carré AM; Léophonte P
    Rev Mal Respir; 1993; 10(4):325-32. PubMed ID: 8235023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causes of acute respiratory failure in the immunocompromised host.
    Ferreyro BL; Munshi L
    Curr Opin Crit Care; 2019 Feb; 25(1):21-28. PubMed ID: 30516586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-flow nasal oxygen vs. standard oxygen therapy in immunocompromised patients with acute respiratory failure: study protocol for a randomized controlled trial.
    Azoulay E; Lemiale V; Mokart D; Nseir S; Argaud L; Pène F; Kontar L; Bruneel F; Klouche K; Barbier F; Reignier J; Stoclin A; Louis G; Constantin JM; Mayaux J; Wallet F; Kouatchet A; Peigne V; Perez P; Girault C; Jaber S; Oziel J; Nyunga M; Terzi N; Bouadma L; Lebert C; Lautrette A; Bigé N; Raphalen JH; Papazian L; Rabbat A; Darmon M; Chevret S; Demoule A
    Trials; 2018 Mar; 19(1):157. PubMed ID: 29506579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coinfection of Pneumocystis jirovecii and invasive pulmonary aspergillosis in an immunocompromised patient: a diagnostic challenge.
    Baumann S; Reinwald M; Haghi D; Hofmann WK; Buchheidt D
    Onkologie; 2013; 36(10):582-4. PubMed ID: 24107913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metagenomic next-generation sequencing of bronchoalveolar lavage fluid from children with severe pneumonia in pediatric intensive care unit.
    Zhang C; Liu T; Wang Y; Chen W; Liu J; Tao J; Zhang Z; Zhu X; Zhang Z; Ming M; Wang M; Lu G; Yan G
    Front Cell Infect Microbiol; 2023; 13():1082925. PubMed ID: 37009495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low prevalence of human metapneumovirus and human bocavirus in adult immunocompromised high risk patients suspected to suffer from Pneumocystis pneumonia.
    Müller A; Klinkenberg D; Vehreschild J; Cornely O; Tillmann RL; Franzen C; Simon A; Schildgen O
    J Infect; 2009 Mar; 58(3):227-31. PubMed ID: 19211148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and outcome of influenza pneumonia in critically-ill immunocompromised patients.
    Raymond M; Martin M; Lamouche-Wilquin P; Blonz G; Decamps P; Agbakou M; Desmedt L; Reignier J; Lascarrou JB; Canet E
    Medicine (Baltimore); 2022 Dec; 101(49):e32245. PubMed ID: 36626482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia.
    Schmiedel Y; Zimmerli S
    Swiss Med Wkly; 2016; 146():w14281. PubMed ID: 26901377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fungal infections in immunocompromised critically ill patients.
    Garnacho-Montero J; Barrero-García I; León-Moya C
    J Intensive Med; 2024 Jul; 4(3):299-306. PubMed ID: 39035612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: A report of two cases and literature review.
    Markantonatou AM; Ioakimidou A; Arvaniti K; Manou E; Papadopoulos V; Kiriklidou P; Samaras K; Kioumi A; Vyzantiadis TA
    Mycoses; 2017 Oct; 60(10):626-633. PubMed ID: 28660636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative PCR (qPCR) Detection of Mucorales DNA in Bronchoalveolar Lavage Fluid To Diagnose Pulmonary Mucormycosis.
    Scherer E; Iriart X; Bellanger AP; Dupont D; Guitard J; Gabriel F; Cassaing S; Charpentier E; Guenounou S; Cornet M; Botterel F; Rocchi S; Berceanu A; Millon L
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29875192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].
    Rodríguez A; Alvarez-Rocha L; Sirvent JM; Zaragoza R; Nieto M; Arenzana A; Luque P; Socías L; Martín M; Navarro D; Camarena J; Lorente L; Trefler S; Vidaur L; Solé-Violán J; Barcenilla F; Pobo A; Vallés J; Ferri C; Martín-Loeches I; Díaz E; López D; López-Pueyo MJ; Gordo F; del Nogal F; Marqués A; Tormo S; Fuset MP; Pérez F; Bonastre J; Suberviola B; Navas E; León C; ; ;
    Med Intensiva; 2012 Mar; 36(2):103-37. PubMed ID: 22245450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of protected BAL in diagnosing pulmonary infections in immunocompromised patients.
    Jolis R; Castella J; Puzo C; Coll P; Abeledo C
    Chest; 1996 Mar; 109(3):601-7. PubMed ID: 8617063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantation.
    Maschmeyer G; Donnelly JP
    Br J Haematol; 2016 Apr; 173(2):179-89. PubMed ID: 26729577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The place of bronchoalveolar lavage in the diagnosis of pneumonia in the immunocompromised patient].
    Georges O; Risso K; Lemiale V; Schlemmer F
    Rev Mal Respir; 2020 Oct; 37(8):652-661. PubMed ID: 32888730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thoracic infections in immunocompromised patients.
    Ahuja J; Kanne JP
    Radiol Clin North Am; 2014 Jan; 52(1):121-36. PubMed ID: 24267714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients.
    Korkmaz Ekren P; Töreyin ZN; Nahid P; Doskaya M; Caner A; Turgay N; Zeytinoglu A; Toz S; Bacakoglu F; Guruz Y; Erensoy S
    Clin Respir J; 2018 Nov; 12(11):2590-2597. PubMed ID: 30244544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Respiratory infections caused by Aspergillus spp. in critically ill patients admitted to the intensive care units].
    Álvarez Lerma F; Olaechea Astigarraga P; Palomar Martínez M; Rodríguez Carvajal M; Machado Casas JF; Jiménez Quintana MM; Esteve Urbano F; Ballesteros Herráez JC; Zavala Zegarra E;
    Med Intensiva; 2015 Apr; 39(3):149-59. PubMed ID: 24713089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.